What caused the decline in US breast cancer incidence?

Nature Clinical Practice Oncology

Volumn 5, Issue 6, 2008, Pages 314-315

  Thorat, Mangesh A ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; HORMONE;

ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; HORMONE SUBSTITUTION; HUMAN; MAMMOGRAPHY; MENOPAUSAL SYNDROME; PRIORITY JOURNAL;

BREAST NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; INCIDENCE; MASS SCREENING; UNITED STATES;

EID: 44649152585     PISSN: 17434254     EISSN: 17434262     Source Type: Journal    
DOI: 10.1038/ncponc1113     Document Type: Article

References (17)

1. Ferley J et al. (2004) GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide. Version 2.0, IARC CancerBase no. 5. Lyon: IARC Press
2. Quinn M and Allen E (1995) Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening: United Kingdom Association of Cancer Registries. BMJ 311: 1391-1395
3. Jatoi I (1999) Breast cancer screening. Am J Surg 177: 518-524
4. Ravdin PM et al. (2007) The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 356: 1670-1674
5. Powles T and Hickish T (1995) Breast cancer response to hormone replacement therapy withdrawal. Lancet 345: 1442
6. Prasad R et al. (2003) Short-term biologic response to withdrawal of hormone replacement therapy in patients with invasive breast carcinoma. Cancer 98: 2539-2546
7. Whitlock EP et al. (1998) Recent patterns of hormone replacement therapy use in a large managed care organization. J Womens Health 7: 1017-1026
8. Writing Group for the Women's Health Initiative I (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative Randomized Controlled Trial. JAMA 288: 321-333
9. Hersh AL et al. (2004) National use of postmenopausal hormone therapy: Annual trends and response to recent evidence. JAMA 291: 47-53
10. Million Women Study (2003) Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362: 419-427
11. Vassilopoulou-Sellin R (2003) Breast cancer and hormonal replacement therapy. Ann NY Acad Sci 997: 341-350
12. Zahl PH and Maehlen J (2007) A decline in breast-cancer incidence. N Engl J Med 357: 510-511
13. Welch HG et al. (2007) Overstating the evidence for lung cancer screening: The International Early Lung Cancer Action Program (I-ELCAP) study. Arch Intern Med 167: 2289-2295
14. Breen N et al. (2007) Reported drop in mammography: Is this cause for concern? Cancer 109: 2405-2409
15. Glass AG et al. (2007) Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst 99: 1152-1161
16. Kerlikowske K et al. (2007) Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst 99: 1335-1339
17. Anderson BO (2007) Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst 99: 1815-1816